Prognostic value of ischemic modified albumin for patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
YAN Shan
ZHANG Xue-feng
TIAN Xiao-yi
LI Jiang-jin
Abstract：Objective To evaluate the prognostic value of ischemic modified albumin (IMA) for patients with acute ST-elevation myocardial infarction (STEMI) receiving primary percutaneous coronary intervention.Methods All 125 patients with STEMI were enrolled.The primary endpoints were major adverse cardiac events (MACE).Receiver operating characteristic (ROC) curves,Kaplan-Meier analysis and Cox regression were used to assess the prognostic value of IMA for 1 year MACE.Results Of 125 patients,22 patients experienced MACE during the 1 year follow up period.ROC showed that IMA were predictors of 1 year major adverse cardiac events.The area under curve was 0.698.Kaplan-Meier analysis showed that IMA had effective prognosis value of 1 year MACE.When IMA was added to a Cox regression model including clinical background factors.IMA levels were independently associated with adverse prognosis[hazard ratio(HR) =1.07,95％ confidence interval:1.03-1.12,P =0.003].Conclusion IMA has an effective prognosis value for 1 year MACE for patients with acute ST-elevation myocardial infarction receiving primary PCI.
Keywords：Acute myocardial infarctionIschemic modified albuminMajor adverse cardiac events
Publication Date：2013-10-30
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：3( 1380-1382 )